<DOC>
	<DOC>NCT02014428</DOC>
	<brief_summary>To evaluate the effectiveness of low molecular weight hyaluronic acid oral tablets for the treatment of atrophic vaginitis.</brief_summary>
	<brief_title>Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis</brief_title>
	<detailed_description />
	<mesh_term>Vaginitis</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Atrophic Vaginitis</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>at least 12 months postmenopausal mucosal atrophy and the main bothersome related symptoms, such as itching, burning, and dyspareunia.</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>